Show
Sort by
-
2021 ESC guidelines on cardiovascular disease prevention in clinical practice
-
Primary prevention efforts are poorly developed in people at high cardiovascular risk : a report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries
-
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies with the special contribution of the European Association of Preventive Cardiology (EAPC)
-
- Journal Article
- A1
- open access
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019 : a pooled analysis of 1201 population-representative studies with 104 million participants
-
- Journal Article
- A1
- open access
Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight
-
- Journal Article
- A1
- open access
National trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio: a pooled analysis of 458 population-based studies in Asian and Western countries
-
- Journal Article
- A1
- open access
Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories : a pooled analysis of 2181 population-based studies with 65 million participants
-
Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries : results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry
-
Blood pressure distribution and control in coronary patients from 24 European countries in the European Society of Cardiology EURoObservational Research Programme European survey of cardiovascular disease prevention and diabetes : EUROASPIRE IV Registry
-
Incidence of cardiovascular events in patients with stabilized coronary heart disease : the EUROASPIRE IV follow-up study